ID   DOK7_HUMAN              Reviewed;         504 AA.
AC   Q18PE1; A2A499; A2RRD4; E9PB56; Q6P6A6; Q86XG5; Q8N2J3; Q8NBC1;
DT   19-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 1.
DT   28-JUN-2023, entry version 137.
DE   RecName: Full=Protein Dok-7;
DE   AltName: Full=Downstream of tyrosine kinase 7;
GN   Name=DOK7; Synonyms=C4orf25;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=16794080; DOI=10.1126/science.1127142;
RA   Okada K., Inoue A., Okada M., Murata Y., Kakuta S., Jigami T., Kubo S.,
RA   Shiraishi H., Eguchi K., Motomura M., Akiyama T., Iwakura Y., Higuchi O.,
RA   Yamanashi Y.;
RT   "The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.";
RL   Science 312:1802-1805(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), PARTIAL NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT ASP-461.
RC   TISSUE=Brain, and Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ARG-296
RP   AND ASP-461.
RC   TISSUE=Blood, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH MUSK, FUNCTION, CHARACTERIZATION OF VARIANTS CMS10 VAL-33
RP   AND GLN-158, AND MUTAGENESIS OF SER-30; VAL-32 AND ARG-174.
RX   PubMed=20603078; DOI=10.1016/j.molcel.2010.06.007;
RA   Bergamin E., Hallock P.T., Burden S.J., Hubbard S.R.;
RT   "The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine
RT   kinase MuSK via dimerization.";
RL   Mol. Cell 39:100-109(2010).
RN   [6]
RP   INVOLVEMENT IN FADS3.
RX   PubMed=19261599; DOI=10.1136/jmg.2008.065425;
RA   Vogt J., Morgan N.V., Marton T., Maxwell S., Harrison B.J., Beeson D.,
RA   Maher E.R.;
RT   "Germline mutation in DOK7 associated with fetal akinesia deformation
RT   sequence.";
RL   J. Med. Genet. 46:338-340(2009).
RN   [7]
RP   VARIANT CMS10 ALA-180.
RX   PubMed=16917026; DOI=10.1126/science.1130837;
RA   Beeson D., Higuchi O., Palace J., Cossins J., Spearman H., Maxwell S.,
RA   Newsom-Davis J., Burke G., Fawcett P., Motomura M., Muller J.S.,
RA   Lochmuller H., Slater C., Vincent A., Yamanashi Y.;
RT   "Dok-7 mutations underlie a neuromuscular junction synaptopathy.";
RL   Science 313:1975-1978(2006).
RN   [8]
RP   VARIANTS CMS10 VAL-33; GLN-132 AND HIS-469.
RX   PubMed=17439981; DOI=10.1093/brain/awm068;
RA   Muller J.S., Herczegfalvi A., Vilchez J.J., Colomer J., Bachinski L.L.,
RA   Mihaylova V., Santos M., Schara U., Deschauer M., Shevell M., Poulin C.,
RA   Dias A., Soudo A., Hietala M., Aarimaa T., Krahe R., Karcagi V.,
RA   Huebner A., Beeson D., Abicht A., Lochmuller H.;
RT   "Phenotypical spectrum of DOK7 mutations in congenital myasthenic
RT   syndromes.";
RL   Brain 130:1497-1506(2007).
RN   [9]
RP   VARIANTS CMS10 MET-116; LEU-146; ARG-157; ARG-171; ARG-172 AND VAL-180, AND
RP   VARIANT LEU-45.
RX   PubMed=20012313; DOI=10.1007/s00415-009-5405-y;
RA   Ben Ammar A., Petit F., Alexandri N., Gaudon K., Bauche S., Rouche A.,
RA   Gras D., Fournier E., Koenig J., Stojkovic T., Lacour A., Petiot P.,
RA   Zagnoli F., Viollet L., Pellegrini N., Orlikowski D., Lazaro L., Ferrer X.,
RA   Stoltenburg G., Paturneau-Jouas M., Hentati F., Fardeau M., Sternberg D.,
RA   Hantai D., Richard P., Eymard B.;
RT   "Phenotype genotype analysis in 15 patients presenting a congenital
RT   myasthenic syndrome due to mutations in DOK7.";
RL   J. Neurol. 257:754-766(2010).
RN   [10]
RP   VARIANTS CMS10 LYS-3; THR-31; MET-77; CYS-109; LEU-139; GLN-158; ARG-161;
RP   ARG-166; ASP-171 AND ALA-180, VARIANTS LEU-45; VAL-99; ASN-197; HIS-261;
RP   GLN-272; ARG-296; CYS-323; LYS-382; GLN-402; SER-415; THR-440; TRP-451;
RP   ASP-461 AND THR-503, CHARACTERIZATION OF VARIANTS CMS10 LYS-3; THR-31;
RP   MET-77; CYS-109; LEU-139; GLN-158; ARG-161; ARG-166; ASP-171 AND ALA-180,
RP   AND CHARACTERIZATION OF VARIANT LEU-45.
RX   PubMed=22661499; DOI=10.1093/hmg/dds198;
RA   Cossins J., Liu W.W., Belaya K., Maxwell S., Oldridge M., Lester T.,
RA   Robb S., Beeson D.;
RT   "The spectrum of mutations that underlie the neuromuscular junction
RT   synaptopathy in DOK7 congenital myasthenic syndrome.";
RL   Hum. Mol. Genet. 21:3765-3775(2012).
CC   -!- FUNCTION: Probable muscle-intrinsic activator of MUSK that plays an
CC       essential role in neuromuscular synaptogenesis. Acts in aneural
CC       activation of MUSK and subsequent acetylcholine receptor (AchR)
CC       clustering in myotubes. Induces autophosphorylation of MUSK.
CC       {ECO:0000269|PubMed:20603078}.
CC   -!- SUBUNIT: Homodimer (By similarity). Forms a heterotetramer composed of
CC       2 DOK7 and 2 MUSK molecules which facilitates MUSK trans-
CC       autophosphorylation on tyrosine residue and activation (By similarity).
CC       Interacts (via IRS-type PTB domain) with MUSK (via cytoplasmic part);
CC       requires MUSK phosphorylation. {ECO:0000250,
CC       ECO:0000269|PubMed:20603078}.
CC   -!- INTERACTION:
CC       Q18PE1; O95967: EFEMP2; NbExp=3; IntAct=EBI-3046647, EBI-743414;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Synapse {ECO:0000250}. Note=Accumulates at
CC       neuromuscular junctions. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q18PE1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q18PE1-2; Sequence=VSP_020633, VSP_020634;
CC       Name=4;
CC         IsoId=Q18PE1-4; Sequence=VSP_047252, VSP_047253;
CC       Name=3;
CC         IsoId=Q18PE1-3; Sequence=VSP_020635;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in skeletal muscle and
CC       heart. Present in thigh muscle, diaphragm and heart but not in the
CC       liver or spleen (at protein level). {ECO:0000269|PubMed:16794080}.
CC   -!- DOMAIN: The PH domain mediated binding to phospholipids with
CC       phosphoinositol headgroups. Affinity is highest for phosphatidyl 3,4,5-
CC       trisphosphate, followed by phosphatidylinositol 3,4-bisphosphate and
CC       phosphatidylinositol 4,5-bisphosphate (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 10 (CMS10) [MIM:254300]: A
CC       form of congenital myasthenic syndrome, a group of disorders
CC       characterized by failure of neuromuscular transmission, including pre-
CC       synaptic, synaptic, and post-synaptic disorders that are not of
CC       autoimmune origin. Clinical features are easy fatigability and muscle
CC       weakness affecting the axial and limb muscles (with hypotonia in early-
CC       onset forms), the ocular muscles (leading to ptosis and
CC       ophthalmoplegia), and the facial and bulbar musculature (affecting
CC       sucking and swallowing, and leading to dysphonia). The symptoms
CC       fluctuate and worsen with physical effort. CMS10 is an autosomal
CC       recessive, post-synaptic form characterized by a typical 'limb girdle'
CC       pattern of muscle weakness with small, simplified neuromuscular
CC       junctions but normal acetylcholine receptor and acetylcholinesterase
CC       function. {ECO:0000269|PubMed:16917026, ECO:0000269|PubMed:17439981,
CC       ECO:0000269|PubMed:20012313, ECO:0000269|PubMed:20603078,
CC       ECO:0000269|PubMed:22661499}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Fetal akinesia deformation sequence 3 (FADS3) [MIM:618389]: A
CC       clinically and genetically heterogeneous group of disorders with
CC       congenital malformations related to impaired fetal movement. Clinical
CC       features include fetal akinesia, intrauterine growth retardation,
CC       polyhydramnios, arthrogryposis, pulmonary hypoplasia, craniofacial
CC       abnormalities, and cryptorchidism. FADS3 inheritance is autosomal
CC       recessive. {ECO:0000269|PubMed:19261599}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11367.1; Type=Miscellaneous discrepancy; Note=Contains a poly-A tail in the 5'region.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=The Leiden Muscular Dystrophy pages, Docking protein
CC       7 (DOK7); Note=Leiden Open Variation Database (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/DOK7";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB220918; BAE96739.1; -; mRNA.
DR   EMBL; AK075037; BAC11367.1; ALT_SEQ; mRNA.
DR   EMBL; AK091037; BAC03572.1; -; mRNA.
DR   EMBL; AL590235; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC043568; AAH43568.1; -; mRNA.
DR   EMBL; BC062369; AAH62369.1; -; mRNA.
DR   EMBL; BC131544; AAI31545.1; -; mRNA.
DR   EMBL; BC141852; AAI41853.1; -; mRNA.
DR   CCDS; CCDS3370.2; -. [Q18PE1-1]
DR   CCDS; CCDS54717.1; -. [Q18PE1-4]
DR   RefSeq; NP_001158145.1; NM_001164673.1. [Q18PE1-4]
DR   RefSeq; NP_001243825.1; NM_001256896.1.
DR   RefSeq; NP_001288000.1; NM_001301071.1. [Q18PE1-3]
DR   RefSeq; NP_775931.3; NM_173660.4. [Q18PE1-1]
DR   AlphaFoldDB; Q18PE1; -.
DR   SMR; Q18PE1; -.
DR   BioGRID; 130124; 9.
DR   IntAct; Q18PE1; 5.
DR   STRING; 9606.ENSP00000344432; -.
DR   iPTMnet; Q18PE1; -.
DR   PhosphoSitePlus; Q18PE1; -.
DR   BioMuta; DOK7; -.
DR   DMDM; 115311705; -.
DR   jPOST; Q18PE1; -.
DR   MassIVE; Q18PE1; -.
DR   PaxDb; Q18PE1; -.
DR   PeptideAtlas; Q18PE1; -.
DR   ProteomicsDB; 19148; -.
DR   ProteomicsDB; 61176; -. [Q18PE1-1]
DR   ProteomicsDB; 61177; -. [Q18PE1-2]
DR   ProteomicsDB; 61178; -. [Q18PE1-3]
DR   Antibodypedia; 55035; 491 antibodies from 28 providers.
DR   DNASU; 285489; -.
DR   Ensembl; ENST00000340083.6; ENSP00000344432.5; ENSG00000175920.18. [Q18PE1-1]
DR   Ensembl; ENST00000507039.5; ENSP00000423614.1; ENSG00000175920.18. [Q18PE1-4]
DR   GeneID; 285489; -.
DR   KEGG; hsa:285489; -.
DR   MANE-Select; ENST00000340083.6; ENSP00000344432.5; NM_173660.5; NP_775931.3.
DR   UCSC; uc003ghd.4; human. [Q18PE1-1]
DR   AGR; HGNC:26594; -.
DR   CTD; 285489; -.
DR   DisGeNET; 285489; -.
DR   GeneCards; DOK7; -.
DR   GeneReviews; DOK7; -.
DR   HGNC; HGNC:26594; DOK7.
DR   HPA; ENSG00000175920; Tissue enhanced (heart muscle, skeletal muscle).
DR   MalaCards; DOK7; -.
DR   MIM; 254300; phenotype.
DR   MIM; 610285; gene.
DR   MIM; 618389; phenotype.
DR   neXtProt; NX_Q18PE1; -.
DR   OpenTargets; ENSG00000175920; -.
DR   Orphanet; 994; Fetal akinesia deformation sequence.
DR   Orphanet; 98913; Postsynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA162384035; -.
DR   VEuPathDB; HostDB:ENSG00000175920; -.
DR   eggNOG; ENOG502QQBI; Eukaryota.
DR   GeneTree; ENSGT00390000015386; -.
DR   HOGENOM; CLU_095366_0_0_1; -.
DR   InParanoid; Q18PE1; -.
DR   OMA; AIICRSQ; -.
DR   OrthoDB; 5394416at2759; -.
DR   PhylomeDB; Q18PE1; -.
DR   TreeFam; TF332288; -.
DR   PathwayCommons; Q18PE1; -.
DR   SignaLink; Q18PE1; -.
DR   SIGNOR; Q18PE1; -.
DR   BioGRID-ORCS; 285489; 5 hits in 1138 CRISPR screens.
DR   ChiTaRS; DOK7; human.
DR   GenomeRNAi; 285489; -.
DR   Pharos; Q18PE1; Tbio.
DR   PRO; PR:Q18PE1; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q18PE1; protein.
DR   Bgee; ENSG00000175920; Expressed in apex of heart and 117 other tissues.
DR   ExpressionAtlas; Q18PE1; baseline and differential.
DR   Genevisible; Q18PE1; HS.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0007528; P:neuromuscular junction development; IBA:GO_Central.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IDA:UniProtKB.
DR   CDD; cd14677; PH_DOK7; 1.
DR   CDD; cd13165; PTB_DOK7; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR037746; Dok-7.
DR   InterPro; IPR037747; Dok-7_PH.
DR   InterPro; IPR037748; Dok-7_PTB.
DR   InterPro; IPR002404; IRS_PTB.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR21636; PROTEIN DOK-7; 1.
DR   PANTHER; PTHR21636:SF2; PROTEIN DOK-7; 1.
DR   Pfam; PF02174; IRS; 1.
DR   SMART; SM01244; IRS; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS51064; IRS_PTB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Congenital myasthenic syndrome;
KW   Disease variant; Lipid-binding; Membrane; Reference proteome; Synapse.
FT   CHAIN           1..504
FT                   /note="Protein Dok-7"
FT                   /id="PRO_0000250371"
FT   DOMAIN          4..109
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          105..210
FT                   /note="IRS-type PTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00389"
FT   REGION          210..229
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          249..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          411..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        259..300
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..351
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        421..444
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..138
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020633"
FT   VAR_SEQ         139..178
FT                   /note="VLARDIPPAVTGQWKLSDLRRYGAVPSGFIFEGGTRCGYW -> MMSSSWPG
FT                   TSPRLSRGSGSCLTSGATGPCQADSSLKAGPG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020634"
FT   VAR_SEQ         175..255
FT                   /note="CGYWAGVFFLSSAEGEQISFLFDCIVRGISPTKGPFGLRPVLPDPSPPGPST
FT                   VEERVAQEALETLQLEKRLSLLSHAGRPG -> GWRLLPVLGRGGADQLPVRLHRPRHL
FT                   PHQGPLWAAAGSTRPKSPGTLDCGGACGPGSPGNPTAGEAAEPPLTCGQAGQWRG (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047252"
FT   VAR_SEQ         256..504
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047253"
FT   VAR_SEQ         500..504
FT                   /note="VNPPP -> GAAASAPGPATAHSGSPGPVAVDSPGPERPRGESPTYVNIPVS
FT                   PSSRKQLHYMGLELQEASEGVRGAGASLYAQIDIMATETAHRVGVRHARAREEQLSELE
FT                   QRKAAPQ (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020635"
FT   VARIANT         3
FT                   /note="E -> K (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs763233743)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068750"
FT   VARIANT         31
FT                   /note="P -> T (in CMS10; results in a significant reduction
FT                   of AChR clusters)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068751"
FT   VARIANT         33
FT                   /note="A -> V (in CMS10; results in reduced stimulation of
FT                   MUSK autophosphorylation)"
FT                   /evidence="ECO:0000269|PubMed:17439981,
FT                   ECO:0000269|PubMed:20603078"
FT                   /id="VAR_068752"
FT   VARIANT         45
FT                   /note="S -> L (does not affect AChR clusters number or
FT                   complexity; dbSNP:rs62272670)"
FT                   /evidence="ECO:0000269|PubMed:20012313,
FT                   ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068753"
FT   VARIANT         77
FT                   /note="T -> M (in CMS10; results in a decrease of branched,
FT                   c-shaped and perforated AChR clusters; dbSNP:rs940346413)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068754"
FT   VARIANT         99
FT                   /note="A -> V (in dbSNP:rs138010842)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068755"
FT   VARIANT         109
FT                   /note="G -> C (in CMS10; results in a significant reduction
FT                   of AChR clusters)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068756"
FT   VARIANT         116
FT                   /note="V -> M (in CMS10; dbSNP:rs1429428597)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068757"
FT   VARIANT         132
FT                   /note="H -> Q (in CMS10)"
FT                   /evidence="ECO:0000269|PubMed:17439981"
FT                   /id="VAR_068758"
FT   VARIANT         139
FT                   /note="V -> L (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs571769859)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068759"
FT   VARIANT         146
FT                   /note="P -> L (in CMS10; dbSNP:rs770987150)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068760"
FT   VARIANT         157
FT                   /note="L -> R (in CMS10)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068761"
FT   VARIANT         158
FT                   /note="R -> Q (in CMS10; reduced stimulation of MUSK
FT                   autophosphorylation when associated with A-174; results in
FT                   a significant reduction of AChR clusters;
FT                   dbSNP:rs754633490)"
FT                   /evidence="ECO:0000269|PubMed:20603078,
FT                   ECO:0000269|PubMed:22661499"
FT                   /id="VAR_031246"
FT   VARIANT         161
FT                   /note="G -> R (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs758131044)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068762"
FT   VARIANT         166
FT                   /note="G -> R (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs781227659)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068763"
FT   VARIANT         171
FT                   /note="G -> D (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs1286619522)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068764"
FT   VARIANT         171
FT                   /note="G -> R (in CMS10)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068765"
FT   VARIANT         172
FT                   /note="G -> R (in CMS10; dbSNP:rs768892432)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068766"
FT   VARIANT         180
FT                   /note="G -> A (in CMS10; results in a significant reduction
FT                   of AChR clusters; dbSNP:rs118203994)"
FT                   /evidence="ECO:0000269|PubMed:16917026,
FT                   ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027544"
FT   VARIANT         180
FT                   /note="G -> V (in CMS10)"
FT                   /evidence="ECO:0000269|PubMed:20012313"
FT                   /id="VAR_068767"
FT   VARIANT         197
FT                   /note="D -> N (in dbSNP:rs16844422)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027545"
FT   VARIANT         261
FT                   /note="R -> H (in dbSNP:rs16844460)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027546"
FT   VARIANT         272
FT                   /note="H -> Q (in dbSNP:rs115614731)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068768"
FT   VARIANT         296
FT                   /note="Q -> R (in dbSNP:rs6811423)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027547"
FT   VARIANT         323
FT                   /note="R -> C (in dbSNP:rs150728781)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068769"
FT   VARIANT         379
FT                   /note="G -> R (in dbSNP:rs6831659)"
FT                   /id="VAR_050508"
FT   VARIANT         382
FT                   /note="E -> K (in dbSNP:rs560463670)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068770"
FT   VARIANT         402
FT                   /note="R -> Q (in dbSNP:rs370039804)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068771"
FT   VARIANT         415
FT                   /note="P -> S (in dbSNP:rs16844464)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027548"
FT   VARIANT         427
FT                   /note="G -> D (in dbSNP:rs2020433)"
FT                   /id="VAR_027549"
FT   VARIANT         440
FT                   /note="A -> T (in dbSNP:rs753026831)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068772"
FT   VARIANT         451
FT                   /note="R -> W (in dbSNP:rs16844470)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027550"
FT   VARIANT         461
FT                   /note="G -> D (in dbSNP:rs9684786)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:22661499"
FT                   /id="VAR_027551"
FT   VARIANT         469
FT                   /note="P -> H (in CMS10; dbSNP:rs147185207)"
FT                   /evidence="ECO:0000269|PubMed:17439981"
FT                   /id="VAR_068773"
FT   VARIANT         503
FT                   /note="P -> T (in dbSNP:rs184556570)"
FT                   /evidence="ECO:0000269|PubMed:22661499"
FT                   /id="VAR_068774"
FT   MUTAGEN         30
FT                   /note="S->W: Reduced stimulation of MUSK
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:20603078"
FT   MUTAGEN         32
FT                   /note="V->A: Reduced stimulation of MUSK
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:20603078"
FT   MUTAGEN         174
FT                   /note="R->A: Reduced stimulation of MUSK
FT                   autophosphorylation; when associated with Q-158."
FT                   /evidence="ECO:0000269|PubMed:20603078"
SQ   SEQUENCE   504 AA;  53097 MW;  54750E0B0BC33317 CRC64;
     MTEAALVEGQ VKLRDGKKWK SRWLVLRKPS PVADCLLMLV YKDKSERIKG LRERSSLTLE
     DICGLEPGLP YEGLVHTLAI VCLSQAIMLG FDSHEAMCAW DARIRYALGE VHRFHVTVAP
     GTKLESGPAT LHLCNDVLVL ARDIPPAVTG QWKLSDLRRY GAVPSGFIFE GGTRCGYWAG
     VFFLSSAEGE QISFLFDCIV RGISPTKGPF GLRPVLPDPS PPGPSTVEER VAQEALETLQ
     LEKRLSLLSH AGRPGSGGDD RSLSSSSSEA SHLDVSASSR LTAWPEQSSS SASTSQEGPR
     PAAAQAAGEA MVGASRPPPK PLRPRQLQEV GRQSSSDSGI ATGSHSSYSS SLSSYAGSSL
     DVWRATDELG SLLSLPAAGA PEPSLCTCLP GTVEYQVPTS LRAHYDTPRS LCLAPRDHSP
     PSQGSPGNSA ARDSGGQTSA GCPSGWLGTR RRGLVMEAPQ GSEATLPGPA PGEPWEAGGP
     HAGPPPAFFS ACPVCGGLKV NPPP
//
